Mednax is trading 4.5% down now at $28.22, with no clear company-specific announcement explaining the October 23 pre-market drop. - It closed at $29.55 on October 22, after gaining 5.16% in the prior session. - Broad markets were under pressure after the prior session’s technology selloff and amid geopolitical concerns, but available evidence does not establish these as direct causes of Mednax’s move. - Mednax’s Q3 results are scheduled for October 29.